Healthcare
Live Price
Offline$0.5764
+0.00% today
1Y Change
+80.12%
Window
Jun 26, 2025 → Jun 18, 2026
Coverage: 252 bars · Jun 26, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Integrated Diagnostics Holdings plc (IDGXF) is a Healthcare stock with a market cap of $17.41B and listed on OTC. The stock last traded around $0.58 and up 80.1% across the available one-year price window (Jun 26, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +37.3%, EPS growth of +19.2%, a dividend yield of 3.0%. What stands out right now is revenue +37.3%, EPS +19.2%, free cash flow +2.9% with operating margin 25.2% and ROIC 14.9%. The dividend matters to the case here, with a current yield around 3.0%. Valuation is more restrained than many high-expectation growth names at P/E 21.1 and price/sales 3.4. Stock Foundry combines IDGXF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
IDGXF
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
IDGXF Max Drawdown
-17.46%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for IDGXF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$2.7B
-49.2% YoY
FY Net Income
$594.0M
-57.9% YoY
Free Cash Flow
$756.5M
-62.3% YoY
Revenue Growth
+37.3%
EPS Growth
+19.2%
Gross Margin
41.1%
Net Margin
16.0%
Income statement
EGP
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 5.7B | 4.1B | 3.6B | 5.2B | 2.7B |
| Gross Profit | 2.2B | 1.5B | 1.5B | 2.8B | 1.3B |
| Operating Income | 1.2B | 738M | 832M | 2.3B | 986M |
| EBITDA | 2.1B | 1.3B | 1.3B | 2.6B | 1.2B |
| Net Income | 1.1B | 510M | 541M | 1.4B | 594M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
EGP
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.2B | 674M | 649M | 891M | 600M |
| Total Assets | 7.1B | 5.8B | 5.3B | 6.2B | 4.2B |
| Total Liabilities | 3.6B | 2.7B | 2.8B | 3.4B | 1.8B |
| Shareholder Equity | 2.7B | 2.7B | 2.2B | 2.6B | 2.3B |
| Total Debt | 1.5B | 1.2B | 1.2B | 859M | 552M |
| Net Debt | 284M | 505M | -532M | -793M | -48M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
883M
-61.1% YoY
Capital Expenditures
126M
+52.2% YoY
Free Cash Flow
757M
-62.3% YoY
Key ratios
Gross Margin
41.1%
Operating Margin
25.2%
Net Margin
16.0%
ROE
27.6%
Debt / Equity
0.43x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.